{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:04:12Z","timestamp":1787508252807,"version":"build-2736575974"},"reference-count":102,"publisher":"Scientific Scholar","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijdvl.ijdvl_633_18","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T07:36:54Z","timestamp":1575013014000},"page":"8","source":"Crossref","is-referenced-by-count":73,"title":["Future therapies in melasma: What lies ahead?"],"prefix":"10.25259","volume":"86","author":[{"given":"Rashmi","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuva","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Ailawadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.272123-1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0190-9622(81)70071-9","article-title":"Melasma: A clinical, light microscopic, ultrastructural, and immunofluorescence study","author":"Sanchez","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.272123-2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-2133.2003.05419.x","article-title":"Development and validation of a health-related quality of life instrument for women with melasma","author":"Balkrishnan","year":"2003","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.272123-3","first-page":"270","article-title":"Translation and cultural adaptation to Portuguese of a quality of life questionnaire for patients with melasma","author":"Cestari","year":"2006","journal-title":"Med Cutan Iber Lat Am"},{"key":"key-10.4103\/0378-6323.272123-4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2133.2006.07591.x","article-title":"Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: The melasQoL-BP study and improvement of qoL of melasma patients after triple combination therapy","author":"Cestari","year":"2006","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.272123-5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1468-3083.2007.02472.x","article-title":"Effect of melasma on quality of life in a sample of women living in Southern Brazil","author":"Freitag","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.272123-6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaad.2006.01.049","article-title":"Melasma in Latina patients: Cross-cultural adaptation and validation of a quality-of-life questionnaire in Spanish language","author":"Dominguez","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.272123-7","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/archderm.1995.01690240119022","article-title":"Melasma.Etiologic and therapeutic considerations","author":"Grimes","year":"1995","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.272123-8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.5021\/ad.2010.22.4.373","article-title":"What should be considered in treatment of melasma","author":"Kang","year":"2010","journal-title":"Ann Dermatol"},{"key":"key-10.4103\/0378-6323.272123-9","doi-asserted-by":"crossref","unstructured":"Kwon SH, Hwang YJ, Lee SK, Park KC. Heterogeneous pathology of melasma and its clinical implications. Int J Mol Sci 2016;17. pii: E824.","DOI":"10.3390\/ijms17060824"},{"key":"key-10.4103\/0378-6323.272123-10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nature05660","article-title":"Melanocyte biology and skin pigmentation","author":"Lin","year":"2007","journal-title":"Nature"},{"key":"key-10.4103\/0378-6323.272123-11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/jid.2013.487","article-title":"Melanin transfer: The keratinocytes are more than gluttons","author":"Delevoye","year":"2014","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.272123-12","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.biocel.2010.03.023","article-title":"Signaling pathways in melanosome biogenesis and pathology","author":"Schiaffino","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"key-10.4103\/0378-6323.272123-13","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/35096009","article-title":"The melanosome: Membrane dynamics in black and white","author":"Marks","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key-10.4103\/0378-6323.272123-14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1600-0749.1989.tb00170.x","article-title":"L-tyrosine, L-dopa, and tyrosinase as positive regulators of the subcellular apparatus of melanogenesis in bomirski Ab amelanotic melanoma cells","author":"Slominski","year":"1989","journal-title":"Pigment Cell Res"},{"key":"key-10.4103\/0378-6323.272123-15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1755-148X.2011.00898.x","article-title":"L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions","author":"Slominski","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"key-10.4103\/0378-6323.272123-16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0190-9622(88)70168-1","article-title":"Biology of hypopigmentation","author":"Bolognia","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.272123-17","doi-asserted-by":"crossref","unstructured":"Taieb A, Cario-Andre M, Brigand S, Picardo M. Inhibitors and enhancers of melanogenesis. In: Riley PA, Borovansky J, editors. Melanins and Melanosomes: Biosynthesis, Biogenesis, Physiological, and Pathological Functions. 1st ed. Wiley Blackwell; Weinheim, Germany; 2011. p. 117-54.","DOI":"10.1002\/9783527636150.ch5"},{"key":"key-10.4103\/0378-6323.272123-18","first-page":"1","article-title":"Comparative action of dopachrome tautomerase and metal ions on the rearrangement of dopachrome","author":"Palumbo","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"key-10.4103\/0378-6323.272123-19","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1038\/515S121a","article-title":"Skin colour: No hiding in the dark","author":"Gupta","year":"2014","journal-title":"Nature"},{"key":"key-10.4103\/0378-6323.272123-20","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1158\/1055-9965.EPI-13-0821","article-title":"Long-term ultraviolet flux, other potential risk factors, and skin cancer risk: A cohort study","author":"Wu","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key-10.4103\/0378-6323.272123-21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1590\/S0365-05962013000100009","article-title":"Mechanisms regulating melanogenesis","author":"Videira","year":"2013","journal-title":"An Bras Dermatol"},{"key":"key-10.4103\/0378-6323.272123-22","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1242\/dev.127.24.5379","article-title":"Signaling and transcriptional regulation in the neural crest-derived melanocyte lineage: Interactions between KIT and MITF","author":"Hou","year":"2000","journal-title":"Development"},{"key":"key-10.4103\/0378-6323.272123-23","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1152\/physrev.00044.2003","article-title":"Melanin pigmentation in mammalian skin and its hormonal regulation","author":"Slominski","year":"2004","journal-title":"Physiol Rev"},{"key":"key-10.4103\/0378-6323.272123-24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1755-148X.2009.00582.x","article-title":"Agouti protein, mahogunin, and attractin in pheomelanogenesis and melanoblast-like alteration of melanocytes: A cAMP-independent pathway","author":"Hida","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"key-10.4103\/0378-6323.272123-25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.dad.0000154419.18653.2e","article-title":"Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma","author":"Grimes","year":"2005","journal-title":"Am J Dermatopathol"},{"key":"key-10.4103\/0378-6323.272123-26","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.0007-0963.2001.04556.x","article-title":"Melasma: Histopathological characteristics in 56 Korean patients","author":"Kang","year":"2002","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.272123-27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1600-0749.1988.tb00140.x","article-title":"Selective cytotoxicity of hydroquinone for melanocyte-derived cells is mediated by tyrosinase activity but independent of melanin content","author":"Smith","year":"1988","journal-title":"Pigment Cell Res"},{"key":"key-10.4103\/0378-6323.272123-28","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0190-9622(87)70294-1","article-title":"Azelaic acid","author":"Nazzaro-Porro","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.272123-29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s004030050320","article-title":"Linoleic acid and alpha-linolenic acid lightens ultraviolet-induced hyperpigmentation of the skin","author":"Ando","year":"1998","journal-title":"Arch Dermatol Res"},{"key":"key-10.4103\/0378-6323.272123-30","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3346\/jkms.2002.17.4.518","article-title":"Therapeutic effect of topical application of linoleic acid and lincomycin in combination with betamethasone valerate in melasma patients","author":"Lee","year":"2002","journal-title":"J Korean Med Sci"},{"key":"key-10.4103\/0378-6323.272123-31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1042\/bj2950309","article-title":"Effect of L-ascorbic acid on the monophenolase activity of tyrosinase","author":"Ros","year":"1993","journal-title":"Biochem J"},{"key":"key-10.4103\/0378-6323.272123-32","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1365-4632.2004.02134.x","article-title":"A double-blind randomized trial of 5% ascorbic acid vs.4% hydroquinone in melasma","author":"Espinal-Perez","year":"2004","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.272123-33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/0974-2077.110089","article-title":"Cosmeceuticals for hyperpigmentation: What is available?","author":"Sarkar","year":"2013","journal-title":"J Cutan Aesthet Surg","ISSN":"https:\/\/id.crossref.org\/issn\/0974-2077","issn-type":"print"},{"key":"key-10.4103\/0378-6323.272123-34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.det.2007.04.012","article-title":"New and experimental treatments of cloasma and other hypermelanoses","author":"Picardo","year":"2007","journal-title":"Dermatol Clin"},{"key":"key-10.4103\/0378-6323.272123-35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/jocd.12147","article-title":"Adouble-blind, placebo-controlled randomized trial of serratulae quinquefoliae folium, a new source of \u03b2-arbutin, in selected skin hyperpigmentations","author":"Morag","year":"2015","journal-title":"J Cosmet Dermatol"},{"key":"key-10.4103\/0378-6323.272123-36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2230.2002.01120.x","article-title":"Aloesin inhibits hyperpigmentation induced by UV radiation","author":"Choi","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/0378-6323.272123-37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4103\/0378-6323.98071","article-title":"Newer and upcoming therapies for melasma","author":"Sarkar","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.272123-38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5021\/ad.2010.22.1.21","article-title":"The efficacy and safety of 4-n-butylresorcinol 0.1% cream for the treatment of melasma: A randomized controlled split-face trial","author":"Huh","year":"2010","journal-title":"Ann Dermatol"},{"key":"key-10.4103\/0378-6323.272123-39","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1562\/0031-8655(2003)078<0256:HGAPAA>2.0.CO;2","article-title":"Hesperetin glucuronide, a photoprotective agent arising from flavonoid metabolism in human skin fibroblasts","author":"Proteggente","year":"2003","journal-title":"Photochem Photobiol"},{"key":"key-10.4103\/0378-6323.272123-40","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1271\/bbb.69.2368","article-title":"Inhibitory effect of an ellagic acid-rich pomegranate extract on tyrosinase activity and ultraviolet-induced pigmentation","author":"Yoshimura","year":"2005","journal-title":"Biosci Biotechnol Biochem"},{"key":"key-10.4103\/0378-6323.272123-41","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0006-2952(98)00340-2","article-title":"Inhibitors of mammalian melanocyte tyrosinase: In vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors","author":"Curto","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"key-10.4103\/0378-6323.272123-42","first-page":"913","article-title":"Tyrosinase inhibitory activities of cinnamic acid analogues","author":"Takahashi","year":"2010","journal-title":"Pharmazie"},{"key":"key-10.4103\/0378-6323.272123-43","first-page":"1859","article-title":"Aloin, cinnamic acid and sophorcarpidine are potent inhibitors of tyrosinase","author":"Tan","year":"2002","journal-title":"Chin Med J (Engl)"},{"key":"key-10.4103\/0378-6323.272123-44","first-page":"s2","article-title":"The use of antisense strategy to modulate human melanogenesis","author":"Lazou","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/0378-6323.272123-45","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.0022-202X.2004.22223.x","article-title":"Involvement of photooxidation of melanogenic precursors in prolonged pigmentation induced by ultraviolet A","author":"Maeda","year":"2004","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.272123-46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9343(00)00481-2","article-title":"Phagocytes and oxidative stress","author":"Babior","year":"2000","journal-title":"Am J Med"},{"key":"key-10.4103\/0378-6323.272123-47","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1248\/bpb.25.1045","article-title":"Mulberroside F isolated from the leaves of Morus alba inhibits melanin biosynthesis","author":"Lee","year":"2002","journal-title":"Biol Pharm Bull"},{"key":"key-10.4103\/0378-6323.272123-48","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1523-1747.2001.01291.x","article-title":"An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway","author":"Paine","year":"2001","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.272123-49","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.3390\/ijms10125326","article-title":"The hunt for natural skin whitening agents","author":"Smit","year":"2009","journal-title":"Int J Mol Sci"},{"key":"key-10.4103\/0378-6323.272123-50","first-page":"497","article-title":"An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma","author":"Grimes","year":"2007","journal-title":"Cutis"},{"key":"key-10.4103\/0378-6323.272123-51","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-0749.1998.tb00494.x","article-title":"The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation","author":"Yokota","year":"1998","journal-title":"Pigment Cell Res"},{"key":"key-10.4103\/0378-6323.272123-52","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1365-4632.2009.04130.x","article-title":"A randomized, double-blind, placebo-controlled trial of oral procyanidin with Vitamins A, C, E for melasma among filipino women","author":"Handog","year":"2009","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.272123-53","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ptr.1537","article-title":"Oral intake of proanthocyanidin-rich extract from grape seeds improves chloasma","author":"Yamakoshi","year":"2004","journal-title":"Phytother Res"},{"key":"key-10.4103\/0378-6323.272123-54","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1524-4725.2010.01481.x","article-title":"Glycolic acid peels versus amino fruit acid peels in the treatment of melasma","author":"Ilknur","year":"2010","journal-title":"Dermatol Surg"},{"key":"key-10.4103\/0378-6323.272123-55","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ptr.1085","article-title":"Treatment of melasma with pycnogenol","author":"Ni","year":"2002","journal-title":"Phytother Res"},{"key":"key-10.4103\/0378-6323.272123-56","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-4362.2000.00943.x","article-title":"Topical liquiritin improves melasma","author":"Amer","year":"2000","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.272123-57","first-page":"917","article-title":"Efficacy of a soy moisturizer in photoaging: A double-blind, vehicle-controlled, 12-week study","author":"Wallo","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/0378-6323.272123-58","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1468-3083.2011.04337.x","article-title":"Defective barrier function in melasma skin","author":"Lee","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.272123-59","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1755-148X.2009.00588.x","article-title":"Evidence that stress to the epidermal barrier influenced the development of pigmentation in humans","author":"Elias","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"key-10.4103\/0378-6323.272123-60","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/jid.2011.109","article-title":"Transcriptional profiling shows altered expression of Wnt pathway- and lipid metabolism-related genes as well as melanogenesis-related genes in melasma","author":"Kang","year":"2011","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.272123-61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jdermsci.2009.10.008","article-title":"UV decreases the synthesis of free fatty acids and triglycerides in the epidermis of human skin in vivo, contributing to development of skin photoaging","author":"Kim","year":"2010","journal-title":"J Dermatol Sci"},{"key":"key-10.4103\/0378-6323.272123-62","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.0022-202X.2004.23235.x","article-title":"Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation","author":"Mao-Qiang","year":"2004","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.272123-63","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jdermsci.2007.01.009","article-title":"The vascular characteristics of melasma","author":"Kim","year":"2007","journal-title":"J Dermatol Sci"},{"key":"key-10.4103\/0378-6323.272123-64","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.0906-6705.2005.00345.x","article-title":"Modulation of vascular endothelial growth factor receptors in melanocytes","author":"Kim","year":"2005","journal-title":"Exp Dermatol"},{"key":"key-10.4103\/0378-6323.272123-65","doi-asserted-by":"crossref","first-page":"191S","DOI":"10.1038\/jid.1993.12","article-title":"Influence of inflammatory mediators and cytokines on human melanocyte function","author":"Morelli","year":"1993","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.272123-66","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1248\/jhs.53.389","article-title":"Mechanism of the inhibitory effect of tranexamic acid on melanogenesis in cultured human melanocytes in the presence of keratinocyte-conditioned medium","author":"Maeda","year":"2007","journal-title":"J Health Sci"},{"key":"key-10.4103\/0378-6323.272123-67","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1468-3083.2012.04464.x","article-title":"Effect of tranexamic acid on melasma: A clinical trial with histological evaluation","author":"Na","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.272123-68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jocd.12026","article-title":"Tranexamic acid: An important adjuvant in the treatment of melasma","author":"Tse","year":"2013","journal-title":"J Cosmet Dermatol"},{"key":"key-10.4103\/0378-6323.272123-69","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/09546634.2011.643220","article-title":"Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS nd: YAG laser","author":"Cho","year":"2013","journal-title":"J Dermatolog Treat"},{"key":"key-10.4103\/0378-6323.272123-70","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s00266-012-9899-9","article-title":"Treatment of melasma with oral administration of tranexamic acid","author":"Wu","year":"2012","journal-title":"Aesthetic Plast Surg"},{"key":"key-10.4103\/0378-6323.272123-71","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2016.03.001","article-title":"Oral tranexamic acid (TA) in the treatment of melasma: A retrospective analysis","author":"Lee","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.272123-72","first-page":"520","article-title":"Oral tranexamic acid with fluocinolone-based triple combination cream versus fluocinolone-based triple combination cream alone in melasma: An open labeled randomized comparative trial","author":"Padhi","year":"2015","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/0378-6323.272123-73","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2230.2008.02724.x","article-title":"Solar elastosis and presence of mast cells as key features in the pathogenesis of melasma","author":"Hern\u00e1ndez-Barrera","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/0378-6323.272123-74","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1007\/s00403-007-0806-1","article-title":"Mast cell tryptase and photoaging: Possible involvement in the degradation of extra cellular matrix and basement membrane proteins","author":"Iddamalgoda","year":"2008","journal-title":"Arch Dermatol Res"},{"key":"key-10.4103\/0378-6323.272123-75","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1365-2133.2003.05113.x","article-title":"The effect of ultraviolet radiation exposure on the prevalence of mast cells in human skin","author":"Grimbaldeston","year":"2003","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.272123-76","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1751-1097.1999.tb07996.x","article-title":"Chronic photodamage in skin of mast cell-deficient mice","author":"Gonzalez","year":"1999","journal-title":"Photochem Photobiol"},{"key":"key-10.4103\/0378-6323.272123-77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2008.03.031","article-title":"Mast cells and tumour angiogenesis: New insight from experimental carcinogenesis","author":"Crivellato","year":"2008","journal-title":"Cancer Lett"},{"key":"key-10.4103\/0378-6323.272123-78","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF01987995","article-title":"Physiological concentrations of zinc inhibit the release of histamine from human basophils and lung mast cells","author":"Marone","year":"1986","journal-title":"Agents Actions"},{"key":"key-10.4103\/0378-6323.272123-79","first-page":"709152","article-title":"Zinc therapy in dermatology: A review","author":"Gupta","year":"2014","journal-title":"Dermatol Res Pract"},{"key":"key-10.4103\/0378-6323.272123-80","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jdv.12049","article-title":"Melasma pathogenesis and influencing factors \u2013 An overview of the latest research","author":"Passeron","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.272123-81","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/pcmr.12404","article-title":"Recent progress in melasma pathogenesis","author":"Lee","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"key":"key-10.4103\/0378-6323.272123-82","first-page":"463","article-title":"Estrogen receptor expression in melasma: Results from facial skin of affected patients","author":"Lieberman","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/0378-6323.272123-83","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1468-3083.2010.03638.x","article-title":"Oestrogen and progesterone receptor expression in melasma: An immunohistochemical analysis","author":"Jang","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.272123-84","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.steroids.2011.06.008","article-title":"Diethylstilbestrol enhances melanogenesis via cAMP-PKA-mediating up-regulation of tyrosinase and MITF in mouse B16 melanoma cells","author":"Jian","year":"2011","journal-title":"Steroids"},{"key":"key-10.4103\/0378-6323.272123-85","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1038\/jid.2012.175","article-title":"PDZK1 upregulation in estrogen-related hyperpigmentation in melasma","author":"Kim","year":"2012","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.272123-86","first-page":"364","article-title":"Quantification of tyrosinase, TRP-1, and trp-2 transcripts in human melanocytes by reverse transcriptase-competitive multiplex PCR \u2013 Regulation by steroid hormones","author":"Kippenberger","year":"1998","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.272123-87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mehy.2017.01.020","article-title":"Melasma treatment: A novel approach using a topical agent that contains an anti-estrogen and a vascular endothelial growth factor inhibitor","author":"Cohen","year":"2017","journal-title":"Med Hypotheses"},{"key":"key-10.4103\/0378-6323.272123-88","first-page":"4219","article-title":"The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: A randomized clinical trial","author":"Adalatkhah","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"key-10.4103\/0378-6323.272123-89","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10875-006-9066-7","article-title":"\u201cSpicing up\u201d of the immune system by curcumin","author":"Jagetia","year":"2007","journal-title":"J Clin Immunol"},{"key":"key-10.4103\/0378-6323.272123-90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2006-960004","article-title":"Pharmacology of Curcuma longa","author":"Ammon","year":"1991","journal-title":"Planta Med"},{"key":"key-10.4103\/0378-6323.272123-91","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/ptr.1553","article-title":"Antioxidant availability of turmeric in relation to its medicinal and culinary uses","author":"Tilak","year":"2004","journal-title":"Phytother Res"},{"key":"key-10.4103\/0378-6323.272123-92","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/exd.12137","article-title":"Curcumin inhibits UVB-induced matrix metalloproteinase-1\/3 expression by suppressing the MAPK-p38\/JNK pathways in human dermal fibroblasts","author":"Hwang","year":"2013","journal-title":"Exp Dermatol"},{"key":"key-10.4103\/0378-6323.272123-93","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1365-4632.2010.04468.x","article-title":"Curcumin targeted signaling pathways: Basis for anti-photoaging and anti-carcinogenic therapy","author":"Heng","year":"2010","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.272123-94","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/BF02942340","article-title":"Decolorization of melanin by lignin peroxidase from Phanerochaete chrysosporium","author":"Woo","year":"2004","journal-title":"Biotechnol Bioprocess Eng"},{"key":"key-10.4103\/0378-6323.272123-95","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1128\/AEM.59.12.4010-4016.1993","article-title":"Decolorization of azo, triphenyl methane, heterocyclic, and polymeric dyes by lignin peroxidase isoenzymes from phanerochaete chrysosporium","author":"Ollikka","year":"1993","journal-title":"Appl Environ Microbiol"},{"key":"key-10.4103\/0378-6323.272123-96","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1473-2165.2011.00581.x","article-title":"A randomized and placebo-controlled study to compare the skin-lightening efficacy and safety of lignin peroxidase cream vs.2% hydroquinone cream","author":"Mauricio","year":"2011","journal-title":"J Cosmet Dermatol"},{"key":"key-10.4103\/0378-6323.272123-97","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/j.1538-7836.2009.03586.x","article-title":"Platelet functions beyond hemostasis","author":"Smyth","year":"2009","journal-title":"J Thromb Haemost"},{"key":"key-10.4103\/0378-6323.272123-98","first-page":"1482","article-title":"Transforming growth factor-beta1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation","author":"Kim","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"key-10.4103\/0378-6323.272123-99","doi-asserted-by":"crossref","first-page":"401","DOI":"10.5021\/ad.2014.26.3.401","article-title":"Regression of melasma with platelet-rich plasma treatment","author":"Cay\u0131rl\u0131","year":"2014","journal-title":"Ann Dermatol"},{"key":"key-10.4103\/0378-6323.272123-100","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1590\/abd1806-4841.20154748","article-title":"Microneedling in facial recalcitrant melasma: Report of a series of 22 cases","author":"Lima","year":"2015","journal-title":"An Bras Dermatol"},{"key":"key-10.4103\/0378-6323.272123-101","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/jdv.14411","article-title":"New data on hyperpigmentation disorders","author":"Schalka","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.272123-102","first-page":"164","article-title":"Double blind placebo controlled trial to evaluate of the effectiveness of a dietary supplement rich in carotenoids as adjunct to topical lightening cream for the treatment of melasma: A pilot study","author":"Teo","year":"2015","journal-title":"J Pigmentery Disord"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T18:32:32Z","timestamp":1722105152000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/future-therapies-in-melasma-what-lies-ahead\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"alternative-id":["272123"],"URL":"https:\/\/doi.org\/10.4103\/ijdvl.ijdvl_633_18","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737030313.793572090","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.737030313.793572841","asserted-by":"object"}]},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}